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ABSTRACT
Background Data: Coccydynia is defined as pain in the coccyx or tailbone area, usually caused by sitting
acutely on a hard object. Because it often runs a chronic course, the management of this medical problem
remains controversial. Different therapeutic options are available for the treatment of this condition.
Purpose: To evaluate the effectiveness of a local betamethasone-17α,21-dipropionate and 21-disodium
phosphate injections versus NSAIDs and physiotherapy in its management.
Study Design: Prospective clinical cases study.
Materials and Methods: Forty-eight patients who presented with pain in the tailbone area for more
than four weeks were recruited for the study. They were subdivided randomly into two groups: Group
I patients were treated with a local injection with betamethasone-17α,21-dipropionate and 21-disodium
phosphate (n = 24), whereas Group II were treated with oral NSAIDs and physiotherapy (n = 24). Oral
diclofenac sodium (150 mg/day) with physiotherapy program was given to patients in Group II for six
weeks. Clinical evaluation was based on the severity of the coccyx pain by Visual Analog Scales (VAS) at
1-, 3-, 6-, and 12-month follow-up and comparison to the baseline pain at presentation.
Results: The incidence was more in the third decade (52%, n = 25), with female overbalance (85%,
n = 40). In Group I, the mean of VAS was 8.1 before treatment and after one month of treatment, the
score reached 3.9 and improved to 0.2 at the end of one year. However, in Group II, the mean of VAS was
7.5 before treatment; then after one month, it changed to 6.6 and improved to 2.5 at the end of one year.
Conclusion: The reported outcome in this study suggests that local betamethasone-17α,21-dipropionate
and betamethasone 21-disodium phosphate injections are more effective than NSAIDs and physiotherapy
for the treatment of coccydynia. (2020ESJ224)
Keywords: coccydynia, local steroids injection, coccyx pain.
Address correspondence and reprint requests: Tarek Abdalla Ahmed, MD.
Orthopaedic Surgery Department, Faculty of Medicine, Minya University, Minia, Egypt.
Email: tarekabdallaahmed@gmail.com
Submitted: July 13th, 2020.
Accepted: September 10th, 2020.
Published: October 2020.

The article does not contain information about medical device(s)/drug(s).
No funds were received in support of this work.
The authors report no conflict of interest.

Egy Spine J - Volume 36 - October 2020

49

The

EGYPTIAN SPINE
Journal
INTRODUCTION
The coccyx is believed to be a vestigial tail, or in
other terms, the “tail bone.” The name coccyx is
acquired from the Greek word for cuckoo due to
its beak-like appearance. Coccydynia takes place in
the lowest part of the spine due to sudden impact of
a fall on a hard object, sitting improperly thereby
straining the coccyx, or after childbirth pressure
in women and rarely due to the undiagnosed
presence of a sacrococcygeal teratoma.14 Women
are affected five times more than men and it can
occur at any age.14 There are no race associations
with coccydynia. The onset of symptoms is
attributed to putting direct stress on the coccyx.
This area is affected by horseback riding, bicycling,
or any activities that increase the pressure on the
coccyx. Coccydynia is often characterized by pain
that worsens with constipation. Sexual intercourse
can aggravate symptoms, but pain may be relieved
with bowel movement. Betamethasone-17α,21dipropionate and 21-disodium phosphate is a
glucocorticoid steroid with immunosuppressive
and anti-inflammatory abilities.1 There is no
consensus on its coherent effectiveness as an antiinflammatory and immunosuppreive.2
The purpose of this study is to evaluate the
effectiveness of a local betamethasone-17α,
21-dipropionate and 21-disodium phosphate
injection versus oral and topical NSAIDs and
physiotherapy in its management.

MATERIALS AND
METHODS
This study was carried out at our university
hospital between June 2015 and June 2017. It
was a prospective randomized study of forty-eight
patients presenting with coccyx pain with a mean
duration of 6.2 ± 2.5 (range, 2–10) weeks. They
were subdivided into two groups. Before starting
the study, we explained the diagnosis and treatment
options, their advantages and disadvantages,
50

and the strategy of our study. Written informed
consent was taken from all patients; then, we
asked every patient to choose one of the sealed
envelopes for treatment allocation. The first group
included 24 patients (5 men and 19 women) with a
mean age of 43.5 ± 5.2 (range, 31–68) years, while
the second group included 24 patients (3 men and
21 women) with a mean age of 44.25 ± 3.6 (range,
30–72) years. Most of them had taken some form
of local treatment in the form of massage or icing.
Five patients in Group I and four in Group II had a
history of trauma with unremarkable radiographs.
All patients who had pain on the coccyx
aggravated by activities (horseback riding and
bicycling), sitting that put direct pressure on the
coccyx, constipation, and sexual intercourse and
improved with bowel movement for at least two
weeks were included. The exclusion criteria were as
follows: a history of receiving previous treatment,
abnormal radiographs, history of treatment with
corticosteroids either locally or generally, history
of contraindications to corticosteroids, suffering
from piles, anal fissure or anal fistula, spinal canal
stenosis, lumbar disc herniation or metastatic
lesions, and duration of symptoms less than two
weeks. Patients gave informed consent for their
procedures and the study was approved by our
hospital’s ethical committee.
Plain X-ray AP and lateral views were taken at
first to exclude old fractures or deformities; then,
an injection of local anesthetic was administered
to the area to test whether the coccyx is involved
or not. If immediate relief of pain in the coccyx
had occurred, the anesthetic test was considered
positive.12 Then, a dynamic (sit/stand) X-ray and
MRI were ordered to show whether the coccyx
dislocates when the patient sits.4 The value of using
dynamic X-rays on 48 patients who gave positive
results with the anesthetic test was expressed as
follows: no abnormality detected hypermobility,
posterior luxation, anterior luxation, and spicule.
At the same time, MRI was used to rule out pain
referred from higher up the spine. Then, the patients
were subdivided into two groups: Group I (n = 24)
was treated by injection of 2 ml of betamethasone-
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68) and in Group II was 46.3 ± 12.3 (range, 30–72)
(p = 0.76). Of them, five patients had controlled
diabetes mellitus, three in Group I and two in
Group II, and another two patients in Group I had
osteoporosis. The pretreatment epidemiological
and clinical data were homogeneous in both
groups (Table 1).
Descriptive statistics was evaluated regarding the
VAS scoring in the two groups. In Group I, results
evaluated within one year revealed that before
treatment, the mean of VAS was 8.1; after one
month of treatment, the score reached 3.9; after
three months, the VAS score reached 1.9; after six
months, it reached 0.6; at one year, it improved
to 0.2. On the other hand, in Group II, before
treatment, the mean of the VAS was 7.5; after
one month, it changed to 6.6; after three months,
the VAS became 5.2; after six months, it changed
to 3.9; at the end of one year, it improved to 2.5.
Analysis of VAS improvement by comparing the
deducted score points after one year in both groups
revealed that the improvement in Group I was
significantly more than that in Group II (Table 2).
Moreover, statistically significant differences were
observed when comparing the mean VAS before
the treatment and after one year in both groups
(Tables 3 and 4).
Pre- and posttreatment VAS scores show variation
between the two groups in each follow-up visit;
scoring indicates continuous improvement of all
patients with rapid and more improvement in
Group I than that in Group II (Figure 1).

17α,21-dipropionate and 21-disodium phosphate
mixed with 1 ml of 2% lidocaine given at the
site of maximum tenderness. Group II (n = 24)
was treated conservatively by oral analgesic antiinflammatory drugs in the form of diclofenac
(100–150 mg/day) and local application of
diclofenac sodium 1% topical gel q.i.d. for six
weeks without massage and physiotherapy in the
form of pulsed ultrasound for 18 sessions (10 min
each) in six weeks, three sessions/week. The
Ultrasonic apparatus used was Phyaction 190;
average pulsed ultrasound intensity was 1.5 W/
cm2 at 1 MHz,
Patients were evaluated clinically after one
month, three months, six months, and one year.
The visual analog scale (VAS) was measured at
the end of these intervals to follow the degree of
improvement.

RESULTS
A total of 48 patients participated and completed
this study after the exclusion of 7 patients who
could not complete the follow-up. Eight patients
(16.6%) were males and 40 (83.4%) were females.
Comparing the sex distribution using the chi-square
x2-test for categorical data resulted in statistical
significance (p < 0.001). The condition is found to
be more common in the age group of 30–39 years,
followed closely by 40–49 years, indicating high
prevalence in the third and fourth decade. The
mean age in Group I was 44.8 ± 11.3 (range, 35–
Table 1. Preprocedural epidemiological parameters.
Parameters

Group I (n = 24)

Group II (n = 24)

p value

Age/years

44.8 ± 11.3 (35–68)

46.3 ± 12.3 (30–72)

0.76**

Male/female

5/19

3/21

0.27*

Duration of symptoms/weeks

6.4 ± 2.2 (3–10)

5.6 ± 2.9 (2–8)

0.12**

History of trauma

5

4

0.2**

Baseline VAS

8.1 ± 5.1

7.5 ± 4.9

0.15**

*Chi-square x -test, **Mann–Whitney U test: for nonparametric quantitative data. Significant if p value < 0.05
2
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Table 2. Comparison between both groups’ Visual Analog Score before and after treatment.
Before treatment
Group
I

Group
II

Mean

8.1

Standard
deviation

0.51

Posttreatment
1 month

3 months

6 months

1 year

Group
I

Group
Il

Group
I

Group
Il

Group
I

Group
II

Group
I

Group
Il

7.5

3.9

6.6

1.9

5.2

0.6

3.9

0.2

2.5

0.49

0.62

0.41

0.72

0.48

0.65

0.46

0.53

0.72

p value
0.15
<0.0001 *
<0.0001 *
*Mann–Whitney U test: for nonparametric quantitative data.
Significant if p value < 0.05.

<0.0001 *

<0.0001 *

Table 3. Group I Visual Analog Score before and after treatment
Posttreatment

1 year
0.2

6 months

3 months

1 month

0.6

1.9

3.9

1 year posttreatment

0.2

6 months posttreatment

0.6

0.029 *

3 months posttreatment

1.9

<0.0001 *

<0.0001 *

1 month posttreatment

3.9

<0.0001 *

<0.0001 *

<0.0001 *

Before treatment
8.1 <0.0001 *
<0.0001 *
*Mann–Whitney U test: for nonparametric quantitative data.
Significant if p value < 0.05.

<0.0001 *

Before treatment
8.1

<0.0001 *

Table 4. Group II Visual Analog Score before and after treatment.
Posttreatment/months

1 year
2.5

6 months

3 months

1 month

3.9

5.2

6.6

Before treatment
7.5

1 year posttreatment

2.5

6 months posttreatment

3.9

<0.0001 *

3 months posttreatment

5.2

<0.0001 *

<0.0001 *

1 month posttreatment

6.6

<0.0001 *

<0.0001 *

<0.0001 *

Before treatment
7.5 <0.0001 *
<0.0001 *
*Mann–Whitney U test: for nonparametric quantitative data.
Significant if p value < 0.05.

<0.0001 *
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Figure 1. Box plots of pre- and posttreatment VAS scores show variation between the two groups in each follow-up
visit; scoring indicates continuous improvement of all patients with rapid and more improvement in Group I than
that in Group II. Right and left whiskers represent 1.5 times and −1.5 times interquartile range; right and left hinges
represent 25% and 75% quartiles; middle represents median or 50% quartile.

DISCUSSION
Coccydynia is an expression meaning pain
in the tailbone area, which is known as the
coccyx.9 Usually, it is effectuated by sitting too
precipitously, while sometimes overstressing the
coccyx is induced while doing daily activities, like
horseback riding and sitting on hard surfaces for
a long period. It is also termed coccygeal pain,
coccygodynia, coxalgia, and coccyx pain.9
It occurs in the lowest part of the spine, which is
considered a vestigial tail, or the “tail bone.” Due
to its beak-like appearance, it is called the coccyx,
which is a name derived from the Greek word
for the cuckoo. The coccyx itself consists of 3–5
vertebrae, some of which may be fused.16 The
anterior aspect of the coccyx is concave, whereas
the posterior aspect is convex. Both sides have
transverse grooves that show where the vestigial
coccygeal units had previously fused. The coccyx
is attached to the sacrum from the dorsal grooves,
being attached with either a symphysis or a true
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synovial joint and the gluteus maximus muscle,
the coccygeal muscle, and the anococcygeal
ligament.8
The most common two causes of coccydynia are
sudden impact due to fall and childbirth pressure
in women. For the coccydynia diagnosis of the
coccyx, we must determine if the pain is related to
the coccyx and/or the attached muscles. This can
be done by rectal examination and radiologically
by MRI scans or high-resolution X-rays to exclude
the other causes unrelated to the coccyx, such as
Tarlov cysts and pain referred from higher up the
spine.6 By the injection of local anesthetic into
the area of the coccyx, we can say that the pain
relates to the coccyx if immediate relief of pain
occurred.12 If the previous test is positive, we can
do a dynamic (sit/stand) X-ray or MRI scan to
reveal if the coccyx subluxates or dislocates when
the patient sits.13
Maigne et al. 9 worked on 208 patients using
dynamic X-rays that were positive with the
anesthetic test; the results were as follows: in 31%
of the patients, not possible to identify the cause
53
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of pain; 27%, hypermobility (excessive flexing of
the coccyx forwards and upwards when sitting);
22%, posterior luxation (partial dislocation of
the coccyx backward when sitting); 14%, spicule
(bone spur) on the coccyx; 5%, anterior luxation
(partial dislocation of the coccyx forwards when
sitting). They also found that obese patients were
most likely to have posterior luxation of the
coccyx, while coccygeal spicules usually occur in
thin patients.
Activities that put pressure on the affected
area are bicycling, horseback riding, and other
activities such as increased sitting that puts direct
stress on the coccyx. The medical condition is
often characterized by pain that worsens with
constipation and may be relieved with bowel
movement. Rarely, even sexual intercourse can
aggravate symptoms.10 Because sitting on the
tailbone area may increase the pain in the coccyx,
it is recommended to use a pillow with a cutout
back to be under the coccyx. Laxatives and fiberrich diet that make the stool soft can be used if
there is coccyx pain with bowel movements; antiinflammatory drugs such as NSAIDs and
skeletal muscle relaxants can be used if the pain
persists.14
Thiele and George17 reported that in a series of
169 coccydynia patients, the cure rate was 63% for
those patients who suffered from coccydynia after
a frequent massage to the muscles attached to the
coccyx via the anus, given by a physical therapist,
chiropractor, or osteopath.
Foye et al.3 reported that treatment of coccydynia
cases by the repeated injection and even a single
injection at the ganglion impar by temporary or
permanent nerve block sufficiently relieves pain.
Foye et al.3 recommended the use of mesotherapy,
which is used for various painful conditions for
the treatment of coccydynia. Mesotherapy is done
using many small injections of various substances
in small amounts. Injections are made just under
the skin with short needles or an electronic injector
locally at the site of pain.
Prolotherapy can also be used for coccydynia; it is
a ligament repair treatment done by injecting an
54

irritant solution such as glucose solution into the
ligaments and the ligament/bone interface, and
this solution causes inflammation that results in
shorter and stronger ligaments. Khan et al.5 found
that by treating 37 patients with prolotherapy, 30
patients experienced good pain relief, while the
other seven patients had no improvement.
Clemens Franzmayr18 reported that injection of
local anesthetic (lignocaine 1%) to trigger points,
in cases of coccydynia repeatedly up to five times,
has the same results as cortisone injections, but
with no side effects. Betamethasone-17α,21dipropionate and 21-disodium is a long-acting
corticosteroid and a strong anti-inflammatory
drug. In patients with coccyx pain, an injection
of corticosteroid can reduce or eliminate the
pain for a period of a month to a year, but not
permanently for most patients. Repeated injections
of corticosteroids can cause thinning of the tissue,
so it is not recommended to give more than two or
three injections14
Surgical treatment by excision of the coccyx
(coccygectomy) can be done after failure of
the conservative treatments to improve the
coccydynia.7 Moreover, in cases of cancer of the
coccyx, a coccygectomy can be done. If the pain
persists after surgery, the drugs for chronic pain,
such as tricyclic antidepressants, can be used to
improve the pain.4,15
In our study, the locally treated group showed
better outcomes relative to the systemically treated
group according to follow-up VAS results. Maigne
and Tamalet11 treated 86 coccydynia patients by
local injection under fluoroscopic guidance and
reported that 50% of the patients with subluxation
or hypermobility and 27% of the patients with no
visible abnormality experienced improvement,
while Foye et al.3 reported that local injection at
ganglion impar will lead to relief of pain in some
cases and even after a single injection.
The limitations of the study include the small
sample size of patients and the short follow-up
period of the study; thus, we recommend a large
size study group of patients for long-term followup, which includes other methods of therapy.
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CONCLUSION
The reported outcome in this study suggests
that local betamethasone-17α,21-dipropionate
and 21-disodium phosphate injections are more
effective than NSAI and physiotherapy in treating
coccydynia.
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الملخص العربي
تقييـم علاج ألـم العصعـص عـن طريـق الحقـن الموضعـي للبيتاميثـازون  17αو  21ديبروبيونـات و  21ثنائـي
فوسفات الصوديوم مقابل  NSAIوالعالج الطبيعي.

عادة بسبب الجلوس
ً
عرف العصعص على أنه ألم في العصعص أو منطقة عظم الذنب  ،يحدث
البيانات الخلفيةُ :ي َّ
غالبـا مـا تسـير في مسـار مزمن ،تظـل إدارة هذه المشـكلة الطبية مثيرة
نظـرا ألنهـا ً
بطريقـة حـادة علـى جسـم صلـبً .
للجدل.
الغرض :تقييم فعالية حقن بيتاميثازون  17و  21ديبروبيونات و  21ثنائي صوديوم فوسفات مقابل  NSAIوالعالج
الطبيعي في إدارتها.

تصميم الدراسة :دراسة حاالت سريرية مستقبلية

عامـا)  ،يعانـون مـن ألـم فـي منطقـة عظم الذنب
ً
المرضـي والطـرق48 :
مريضـا كان متوسـط عمرهـم  31( ،إلـى ً 72
لمـدة تزيـد عـن أربعـة أسـابيع  ،تـم تجنيدهـم للدراسـة .كان معـدل اإلصابـة أكثـر فـي العقـد الثالـث ( ٪ 52ن = ، )25
مـع زيـادة التـوازن بيـن اإلنـاث ( ٪ 85ن =  .)40يتـم تقسـيمها إلـى مجموعتيـن .تـم توزيـع مرضـى المجموعـة األولـى
علـى التوالـي علـى العلاج بحقـن موضعيـة مـع بيتاميثـازون  17αو  21ديبروبيونات و  21ثنائي فوسـفات الصوديوم
(ن =  ، )24بينمـا تـم علاج المجموعـة الثانيـة بواسـطة مضـادات االلتهـاب غيـر السـتيروئيدية عن طريق الفم والعالج
الطبيعي (ن =  .)24أعطيت المجموعه االولى حقن  2مل من بيتاميثازون  17αو 21-ديبروبيونات و 21-فوسفات
ثنائي الصوديوم ممزوجة مع 2مل من  ٪ 2ليدوكائين لكل مريض في موقع أقصى قدر من االلم .وتم إعطاء في
المجموعة الثانية ( 150ملغ ديكلوفينات صوديم) أو ( 20ملغ بيروكسيكام  /يوم) أو إيبوبروفين ( 1200ملغ  /يوم)
مع برنامج العالج الطبيعي للمرضى.

النتائج :يعتمد التقييم على شـدة ألم العصعص والحنان ومقياس  )visual analog scale (VASبعد شـهر وثالث
اشـهر وسـته اشـهر وبعـد مـرور عـام  ،والمتابعـة والمقارنـة مـع السـمات السـريرية األساسـية و عنـد العـرض تم تقييم
النتيجة في غضون عام واحد ,في المجموعة األولى  ،كان متوسط  VAS 8.1سم قبل العالج وبعد شهر واحد من
العالج وصلت النتيجة إلى  3.9سـم  ،وبعد ثالثة أشـهر وصلت درجة  VASإلى  1.9سـم  ،وبعد  6أشـهر وصلت إلى
 0.6سم وتحسن  VASإلى  0.2سم في نهاية عام واحد .بينما في المجموعة الثانية  ،كان متوسط  VAS 7.5سم
قبل العالج ثم بعد شـهر واحد تغير إلى  6.6سـم  ،وبعد ثالثة أشـهر أصبح  VAS 5.2سـم ثم تغير إلى  3.9بعد سـتة
أشهر وتحسن إلى  2.5سم بعد عام واحدة.
الخالصة :إن حقن البيتاميثازون الموضعي  17ألفا و  21ديبروبيونات و  21ثنائي فوسـفات الصوديوم أكثر فعالية
من العالج الطبيعي و  ، NSAIلعالج الم العصعص.
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